Followers | 146 |
Posts | 27518 |
Boards Moderated | 4 |
Alias Born | 02/07/2004 |
Tuesday, October 04, 2022 10:32:01 AM
After being diagnosed with high-risk leukemia, Jesus Torres needed a bone marrow transplant if he was to have any chance of a cure. Like many Hispanics, he faced challenges finding a matching donor in the international donor pool. Fortunately, his hematologist Patrick Hagen, MD, was able to enroll Jesus in a clinical trial studying a new treatment using umbilical cord blood as his donor source. Just three months after his transplant, Jesus had no signs of leukemia and is living a normal life now.
Recent GMDA News
- U.S. Stock Index Futures Point to a Rebound, Oil See Declines in Early Trading • IH Market News • 03/27/2024 10:57:08 AM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 07:14:47 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/02/2024 09:45:46 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/02/2024 09:40:35 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/02/2024 09:38:53 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/02/2024 09:37:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/02/2024 09:35:40 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/29/2024 11:31:15 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/08/2024 12:00:12 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/18/2023 11:28:49 AM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 12/15/2023 05:15:29 AM
- Form S-3/A - Registration statement under Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 12/06/2023 10:24:47 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/24/2023 09:15:22 PM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 11/20/2023 10:27:26 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 11/15/2023 10:24:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/15/2023 12:00:38 PM
- Gamida Cell Reports Third Quarter 2023 Financial Results and Provides Company Update • GlobeNewswire Inc. • 11/14/2023 12:00:00 PM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 11/08/2023 09:05:08 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/20/2023 08:40:48 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/20/2023 08:01:23 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 10/11/2023 11:07:56 AM
Endexx Corporation (EDXC) Leverages Global Market Trends and Legislative Reforms to Spearhead Growth in the Cannabis and Plant-Based Wellness Sectors • EDXC • Mar 27, 2024 3:01 PM
Applied UV, Inc. Announces Pricing of $2.76 Million Registered Direct and Private Placement Priced at the Market Under Nasdaq Rules • AUVI • Mar 27, 2024 2:51 PM
POET and MultiLane Collaborate to Develop High-Speed Pluggable Transceivers for AI Networks • POET • Mar 27, 2024 10:52 AM
Maybacks Global Entertainment Opens 23 More Stations in Important Major Cities • AHRO • Mar 27, 2024 9:00 AM
NxGen Brands Inc. Forecast to Deliver 140% Growth in Q1 2024 • NXGB • Mar 27, 2024 7:30 AM
Kona Gold Beverages, Inc. Strategic Advancements: Covert LLC Introduces Federally Legal D9 Gummies and Revamps Innovative eCommerce Platform, Propelling Toward $12 Million Annual Revenue Goal • KGKG • Mar 26, 2024 8:30 AM